Washington, May9 (BNA): Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general and…Read More
COVID19 vaccine maker Novavax to chop workforce expenses
